Health&Life Co

Health&Life Co Interest Expense

The Interest Expense of Health&Life Co (1781.TWO) as of Oct 29, 2026 is 18.19 M TWD. In the previous year, Interest Expense was 890,000.00 TWD — a change of 1,943.26% (higher).

Interest Expense

18.19 MTWD

YoY

1,943.26%

Last updated:

Interest Expense of Health&Life Co is 2024 18.19 M TWD. Interest Expense of Health&Life Co was 2023 890,000.00 TWD. It decreases by 1,943.26% higher compared to the previous year.

The Health&Life Co Interest Expense history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Expense
Date
Interest Expense
Jan 1, 2017
-12.23 M TWD
Jan 1, 2018
6.22 M TWD
Jan 1, 2019
-3.13 M TWD
Jan 1, 2020
275.58 M TWD
Jan 1, 2021
23.15 M TWD
Jan 1, 2022
20.43 M TWD
Jan 1, 2023
890,000.00 TWD
Jan 1, 2024
18.19 M TWD
The Health&Life Co Interest Expense history
YEARInterest ExpenseYoY
18.19 MTWD+1,943.26%
890,000.00TWD-95.64%
20.43 MTWD-11.76%
23.15 MTWD-91.60%
275.58 MTWD-8,893.33%
-3.13 MTWD-150.42%
6.22 MTWD-150.83%
-12.23 MTWD+181.64%
-4.34 MTWD-148.98%
8.87 MTWD-61.53%
23.04 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Health&Life Co Stock analysis

What does Health&Life Co do? Health&Life Co Ltd generates revenue through the manufacturing and distribution of cardiovascular disease, in-vitro diagnostics, and respiratory care products. The company's primary products include electronic sphygmomanometers such as blood pressure monitors, nebulizers, and blood glucose monitoring systems, which measure and record systolic and diastolic blood pressure and glucose levels. These products are sold domestically in Taiwan and internationally to overseas markets. The firm targets healthcare providers, clinics, and consumers seeking home health monitoring solutions for chronic conditions like hypertension and diabetes. The company's product portfolio focuses on electronic sphygmomanometers, which are essential for daily health monitoring. By offering devices that measure blood pressure and glucose levels, Health&Life Co Ltd caters to patients managing cardiovascular and metabolic diseases. The domestic market in Taiwan serves as a key sales channel, while overseas markets provide additional growth opportunities for the firm's diagnostic and respiratory care products. Health&Life Co Ltd's business model relies on direct sales of medical devices to healthcare institutions and end-users. The firm's electronic sphygmomanometers, including blood pressure monitors and blood glucose systems, are distributed through both domestic and international channels. This approach ensures consistent revenue streams from the ongoing demand for home health monitoring equipment among patients with chronic conditions. Health&Life Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Health&Life Co stock

Interest Expense of Health&Life Co is 18.19 M TWD in 2024.

Interest Expense of Health&Life Co changed from 890,000.00 TWD to 18.19 M TWD, representing a 1,943.26% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Expense Health&Life Co since 2006 – with annual values, charts, and detailed analysis.

Interest expense represents the cost of borrowing. Higher interest expenses can indicate a highly leveraged company.

Interest Expense's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Interest Expense's Health&Life Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Health&Life Co

All Key Metrics — Health&Life Co